Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pronethalol ((±)-Pronethalol), a non-selective β-adrenergic antagonist, effectively inhibits Sox2 expression and offers protection against Digitalis-induced ventricular arrhythmias. Additionally, it can reverse such arrhythmias and limit the development of cerebral arteriovenous malformations (AVMs) [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $41 | In Stock | |
1 mL x 10 mM (in DMSO) | $44 | In Stock |
Description | Pronethalol ((±)-Pronethalol), a non-selective β-adrenergic antagonist, effectively inhibits Sox2 expression and offers protection against Digitalis-induced ventricular arrhythmias. Additionally, it can reverse such arrhythmias and limit the development of cerebral arteriovenous malformations (AVMs) [1] [2]. |
In vitro | Pronethalol (2, 10, 20 μM) inhibits EGFP expression in a dose- and time-dependent manner in ReNcell VM cells, with 10 μM reducing Sox2 expression to less than 10% after 2 days of treatment [2]. |
In vivo | Pronethalol (0.15 mg/g; daily; for 14 days) stabilizes endothelial differentiation and lumen formation, thereby limiting cerebral arteriovenous malformations (AVMs) in Mgp –/– mice [2]. |
Molecular Weight | 229.32 |
Formula | C15H19NO |
Cas No. | 54-80-8 |
Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 10 mM | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.